Hepcidin as a potential biomarker for blood doping.

Details

Serval ID
serval:BIB_014250D79895
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Hepcidin as a potential biomarker for blood doping.
Journal
Drug testing and analysis
Author(s)
Leuenberger N., Bulla E., Salamin O., Nicoli R., Robinson N., Baume N., Saugy M.
ISSN
1942-7611 (Electronic)
ISSN-L
1942-7603
Publication state
Published
Issued date
07/2017
Peer-reviewed
Oui
Volume
9
Number
7
Pages
1093-1097
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
The concentration of hepcidin, a key regulator of iron metabolism, is suppressed during periods of increased erythropoietic activity. The present study obtained blood samples from 109 elite athletes and examined the correlations between hepcidin and markers of erythropoiesis and iron metabolism (i.e., haemoglobin, erythropoietin (EPO), ferritin, erythroferrone (ERFE), and iron concentration). Furthermore, an administration study was undertaken to examine the effect of recombinant human EPO (rhEPO) delta (Dynepo™) on hepcidin concentrations in healthy male volunteers. The effects on hepcidin were then compared with those on reticulocyte percentage (Ret%) and ferritin concentration. There was a significant positive correlation between hepcidin and ferritin, iron, and haemoglobin levels in athletes, whereas hepcidin showed an inverse correlation with ERFE. Administration of rhEPO delta reduced hepcidin levels, suggesting that monitoring hepcidin may increase the sensitivity of the Athlete Biological Passport (ABP) for detecting rhEPO abuse. Copyright © 2016 John Wiley & Sons, Ltd.

Keywords
EPO, blood doping, hepcidin
Pubmed
Web of science
Create date
01/11/2016 19:34
Last modification date
20/08/2019 12:23
Usage data